FORT LEE, N.J., Oct. 9, 2025 /PRNewswire/ -- Kedrion Biopharma is proud to announce the U.S. availability of YIMMUGO (Immune Globulin Intravenous, Human-dira, 10%), marking a major milestone in the ...
The similarities between gestational alloimmune liver disease and FNAIT suggest that applying comparable treatment strategies and timing may improve outcomes in pregnancies at risk for fetal ...
Background Regarding the close association between neonatal hyperbilirubinemia and occurrence of pathological jaundice as a cause of neurotoxicity and kernicterus, the present study aimed to evaluate ...
Grifols, a global healthcare company and producer of plasma-derived medicines, has shared positive results from its phase 2/3 clinical trial (NCT02176863) evaluating the efficacy and safety of Grifols ...
Objective Kawasaki disease (KD) is an acute form of febrile vasculitis that occurs in early childhood. The multisystemic vasculitis common in patients with KD may influence blood perfusion in the ...
Neurologist Susan W. Lee, DO, answers common questions about this treatment option for myasthenia gravis. Intravenous immunoglobulin (IVIG) is a pooled collection of antibodies derived from donors’ ...
CIDP is a treatable condition that affects the peripheral nervous system. IVIG, plasma exchange, and corticosteroid therapy are the first-line treatment options, but a newer medication for adults has ...
Objectives Regular intravenous immunoglobulin (IVIg) is commonly used for autoimmune neurological conditions. In our hospital, 388 patients received 203,571 grams of IVIg in 2014/15 amounting to 3127 ...
Prophylactic intravenous immunoglobulin reduces COVID-19 infection rates in older patients with DLBCL with hypogammaglobulinemia undergoing reduced-intensity R-CHOP therapy. The study, conducted ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback